MicroPort CardioFlow Medtech (HKSE:02160) Gross-Profit-to-Asset % : 8.27% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. MicroPort CardioFlow Medtech's annualized Gross Profit for the quarter that ended in Dec. 2023 was HK$247.9 Mil. MicroPort CardioFlow Medtech's average Total Assets over the quarter that ended in Dec. 2023 was HK$2,995.7 Mil. Therefore, MicroPort CardioFlow Medtech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 8.27%.

MicroPort CardioFlow Medtech Gross-Profit-to-Asset % Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Gross-Profit-to-Asset % Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

1.32

5.59

5.35

4.85

8.15

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial					4.25	4.72	5.18	7.82	8.27

Competitive Comparison of MicroPort CardioFlow Medtech's Gross-Profit-to-Asset %

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort CardioFlow Medtech's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Gross-Profit-to-Asset % falls into.

MicroPort CardioFlow Medtech Gross-Profit-to-Asset % Calculation

MicroPort CardioFlow Medtech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	251.494	/	( (3351.552	+	2818.786)	/ 2 )
	=	251.494	/	3085.169
	=	8.15 %

MicroPort CardioFlow Medtech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	247.868	/	( (3172.516	+	2818.786)	/ 2 )
	=	247.868	/	2995.651
	=	8.27 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

MicroPort CardioFlow Medtech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines